210 related articles for article (PubMed ID: 27021762)
1. Methods Used in Economic Evaluations of Tuberculin Skin Tests and Interferon Gamma Release Assays for the Screening of Latent Tuberculosis Infection: A Systematic Review.
Koufopoulou M; Sutton AJ; Breheny K; Diwakar L
Value Health; 2016; 19(2):267-76. PubMed ID: 27021762
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in high-risk groups.
Auguste P; Tsertsvadze A; Court R; Pink J
Tuberculosis (Edinb); 2016 Jul; 99():81-91. PubMed ID: 27450009
[TBL] [Abstract][Full Text] [Related]
3. Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis.
Pareek M; Bond M; Shorey J; Seneviratne S; Guy M; White P; Lalvani A; Kon OM
Thorax; 2013 Mar; 68(3):230-9. PubMed ID: 22693179
[TBL] [Abstract][Full Text] [Related]
4. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
Haukaas FS; Arnesen TM; Winje BA; Aas E
Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of concordance and costs between tuberculin skin test and QuantiFERON(®)-TB Gold In-Tube in the diagnosis of latent tuberculosis infection among contacts of patients with pulmonary tuberculosis].
Martinez Lacasa X; Canals Font R; Jaen Manzanera A; Cuchi Burgos E; Lite Lite J
Med Clin (Barc); 2015 Nov; 145(10):427-32. PubMed ID: 25794770
[TBL] [Abstract][Full Text] [Related]
6. Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands.
Erkens CG; Dinmohamed AG; Kamphorst M; Toumanian S; van Nispen-Dobrescu R; Alink M; Oudshoorn N; Mensen M; van den Hof S; Borgdorff M; Verver S
Int J Tuberc Lung Dis; 2014 Apr; 18(4):413-20. PubMed ID: 24670695
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
[TBL] [Abstract][Full Text] [Related]
8. Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.
Diel R; Lampenius N; Nienhaus A
Pharmacoeconomics; 2015 Aug; 33(8):783-809. PubMed ID: 25774015
[TBL] [Abstract][Full Text] [Related]
9. Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal.
Sousa S; Rocha D; Silva JC; Ribeiro AI; Gonçalves G; Almeida Á; Correia AM; Duarte R; Carvalho C
Pulmonology; 2021; 27(6):493-499. PubMed ID: 34053903
[TBL] [Abstract][Full Text] [Related]
10. How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI.
Oxlade O; Pinto M; Trajman A; Menzies D
PLoS One; 2013; 8(3):e56044. PubMed ID: 23505412
[TBL] [Abstract][Full Text] [Related]
11. Methodological considerations for economic modelling of latent tuberculous infection screening in migrants.
Shedrawy J; Siroka A; Oxlade O; Matteelli A; Lönnroth K
Int J Tuberc Lung Dis; 2017 Sep; 21(9):977-989. PubMed ID: 28826446
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective.
Kowada A
J Infect; 2019 Jan; 78(1):58-65. PubMed ID: 30009853
[TBL] [Abstract][Full Text] [Related]
13. A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries.
Zammarchi L; Casadei G; Strohmeyer M; Bartalesi F; Liendo C; Matteelli A; Bonati M; Gotuzzo E; Bartoloni A;
BMC Health Serv Res; 2015 Sep; 15():412. PubMed ID: 26399233
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of latent tuberculosis infection among immunodeficient individuals: review of concordance between interferon-gamma release assays and the tuberculin skin test.
Mamishi S; Pourakbari B; Marjani M; Mahmoudi S
Br J Biomed Sci; 2014; 71(3):115-24. PubMed ID: 25265757
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of targeted and sequential screening strategies for latent tuberculosis.
Mancuso JD; Niebuhr DW; Frick KD; Keep LW; Anderson KM
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1223-30, i. PubMed ID: 21943850
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y
Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
[TBL] [Abstract][Full Text] [Related]
18. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Kahwati LC; Feltner C; Halpern M; Woodell CL; Boland E; Amick HR; Weber RP; Jonas DE
JAMA; 2016 Sep; 316(9):970-83. PubMed ID: 27599332
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.
del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J
Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of Quantiferon-TB Gold in Tube® in screening for latent tuberculosis infection in health workers].
Martinez-Lacasa X; Font R; Gonzalez S; Sallent S; Jaen A; Lite J; Cuchi E
Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):525-31. PubMed ID: 25613557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
